Loading stock data…
Check-Cap Ltd. (MBAI)
$1.26+0.17 (+15.60%)
Market ClosedLast close Jun 29
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Check-Cap Ltd. in the Healthcare sector is trading at $1.26 with a market capitalization of $12M. The stock is currently 68% below its 52-week high of $3.92, remaining 25.9% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|
| Total Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | — | — | — | — |
Peer Comparison
JNJUNHPFE
Fundamentals
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.83M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
2.32
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
315,071
